Skip to main content
Caplight Logo









Riboway Therapeutics

Riboway Therapeutics

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://riboway.com/

Company Overview

Riboway Therapeutics is a biotechnology company that develops AI-powered RNA-targeted therapeutics to control protein expression and function.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

RNA therapeuticsdrug discoveryantisense oligonucleotidesASORNA targetingbiotechsmall molecule drugsAI drug discoveryundruggable targetsbioinformaticsgene expression modulationdrug pipelinebiotech platformin silico drug design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Riboway Therapeutics Comparables

Compare Riboway Therapeutics with similar companies based on industry and business-model similarity.

Riboway Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Base4 Biotechnology
88%
Atomic AI
87%
Wayfinder Biosciences
85%
View all Comparables

Riboway Therapeutics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Avery Yan

Founder & CEO

Founding Team

Riboway Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Riboway Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Riboway Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range3
Year Founded2024
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?